Verastem | VSTM - Market Capitalization


Verastem reported $244.4M in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 521.8B 77.2B Oct/2026
Alaunos Therapeutics USD 7M 2M Mar/2026
AstraZeneca USD 215.06B 74.93B Oct/2026
Curis USD 22M 9M Mar/2026
Cytokinetics USD 11.55B 3.36B Jun/2026
Gilead Sciences USD 206.51B 21.7B Oct/2026
Incyte USD 26.22B 1.63B Oct/2026
Laboratory Of America USD 30.3B 5.31B Oct/2026
Novartis USD 266.01B 25.42B Oct/2026
Pfizer USD 138.44B 15.37B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
TG Therapeutics USD 8.41B 3.1B Jun/2026
Verastem USD 466M 130M Mar/2026